Akèy › Kansè pwostat › Maryland › Baltimore
Etid klinik pou Kansè pwostat nan Baltimore, MD
43 etid pou Kansè pwostat ap chèche patisipan nan sit nan ak bò kote Baltimore (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Ap rekriteFaz 3
- Maryland Proton Treatment Center, Baltimore
- University of Maryland/Greenebaum Cancer Center, Baltimore
- UM Baltimore Washington Medical Center/Tate Cancer Center, Glen Burnie · 9 mi lwen
- ak 1 plis
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Mercy Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
- ak 2 plis
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Ap rekriteFaz 2
- Johns Hopkins University, Baltimore
Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix
Ap rekriteEtid obsèvasyon
- Chesapeake Urology Associates, Towson · 8 mi lwen
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
Ap rekriteFaz 1
- University of Maryland, Greenebaum Comprehensive Cancer Center, Baltimore
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Ap rekriteFaz 3
- Baltimore Veterans Affairs Medical Center ( Site 0069), Baltimore
- Greenebaum Comprehensive Cancer Center ( Site 0049), Baltimore
- Chesapeake Urology ( Site 0009), Towson · 8 mi lwen
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Ap rekriteFaz 3
- University of Maryland Greenebaum Cancer Center, Baltimore
- Johns Hopkins Hospital Sidney Kimmell Comprehensive Cancer Center, Baltimore
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Ap rekriteFaz 3
- Research Site, Towson · 8 mi lwen
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Ap rekriteFaz 3
- Greenebaum Comprehensive Cancer Center ( Site 0021), Baltimore
PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness
Ap rekriteEtid obsèvasyon
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
Ap rekriteFaz 2
- Chesapeake Urology Research Associates, Towson · 8 mi lwen
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Ap rekrite
- Anne Arundel Urology, Annapolis · 22 mi lwen
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Ap rekriteFaz 3
- Maryland Proton Treatment Center, Baltimore
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Veterans Administration Medical Center-Baltimore, Baltimore
- ak 4 plis
Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients
Ap rekrite
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Transrectal Ultrasound Robot-Assisted Prostate Biopsy
Ap rekrite
- Johns Hopkins Hospital, Baltimore
Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
Ap rekriteFaz 2
- University of Maryland Greenebaum Cancer Center, Baltimore
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
Ap rekriteFaz 1/2
- Johns Hopkins Hospital, Baltimore
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Ap rekriteFaz 3
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1/2
- Johns Hopkins University, The Sidney Kimmel Comprehensive Cancer Center, Baltimore
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Ap rekriteFaz 1
- University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer
Ap rekriteEtid obsèvasyon
- Johns Hopkins University, Baltimore
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Ap rekriteFaz 3
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
Ap rekriteFaz 2
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Ap rekriteFaz 1
- Marlene & Stewart Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore
7-Days Water-Only Fasting or Ketone Supplementation Trial in Prostate Cancer
Ap rekrite
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
The COSMYC Trial (COmbined Suppression of MYC)
Ap rekriteFaz 2
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Ap rekriteFaz 1
- Advanced Molecular Imaging and Therapy, Glen Burnie · 9 mi lwen
- United Theranostics - Chesapeake, Glen Burnie · 9 mi lwen
TERPS Trial for de Novo Oligometastic Prostate Cancer
Ap rekriteFaz 2
- Maryland Proton Treatment Center, Baltimore
- UMMC, Baltimore
- Baltimore Washington Medical Center, Glen Burnie · 9 mi lwen
- ak 1 plis
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Ap rekriteEtid obsèvasyon
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Clinical Trial of Approaches to Prostate Cancer Surgery
Ap rekrite
- Johns Hopkins University, Baltimore
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Ap rekriteFaz 2/3
- Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD, Baltimore
SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment Optimization
Ap rekriteEtid obsèvasyon
- Johns Hopkins University, Baltimore
Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response
Ap rekriteFaz 2
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer
Ap rekriteFaz 2
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT
Ap rekriteFaz 1 bonè
- SKCCC at Johns Hopkins, Baltimore
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Ap rekriteFaz 1
- Johns Hopkins - Sidney Kimmel Comprehensive Cancer Center, Baltimore
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
Ap rekriteFaz 1
- Chesapeake Urology, Towson · 8 mi lwen
Physician- and Patient-based Barriers to NGS Testing
Ap rekrite
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
Ap rekriteFaz 2
- Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center, Baltimore
Robot-Assisted Prostate Biopsy With a Novel Ultrasound Probe
Ap rekriteFaz 1
- Johns Hopkins Hospital, Baltimore
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Towson · 8 mi lwen
Exercise in Prostate Cancer
Ap rekrite
- Johns Hopkins University, Baltimore
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
Ap rekriteFaz 1/2
- Johns Hopkins, Baltimore
Etid Kansè pwostat nan lòt vil
- New York City, NY103 etid
- Houston, TX76 etid
- Los Angeles, CA61 etid
- Boston, MA59 etid
- St. Louis, MO46 etid
- Chicago, IL45 etid
- San Francisco, CA45 etid
- Philadelphia, PA44 etid
- Nashville, TN42 etid
- Seattle, WA42 etid
- Washington, DC38 etid
- Dallas, TX36 etid
Lòt etid nan Baltimore
- Kansè Poumon ki pa ti selil60 etid
- Kansè nan tete47 etid
- Kansè poumon40 etid
- Kansè (tout kalite)37 etid
- Kansè kolorektal31 etid
- Kansè pankreyas31 etid
- Kansè Metastatik28 etid
- Obèsite25 etid
- Ensifizyans kadyak24 etid
- Kansè vejik24 etid
- Akidan serebavaskilè22 etid
- Kansè ovè22 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.